• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Ubiquitin-conjugating enzyme E2Q-like protein 1 (UBE2QL1)

ACP19994

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19994 Target NameUBE2QL1
Target SynonymsUBE2QL1; Ubiquitin-conjugating enzyme E2Q-like protein 1; EC 2.3.2.23; E2Q-like ubiquitin-conjugating enzyme 1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-161
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDA1L167
Background Information
  • Uniprot Id

    A1L167

  • Target Species

    Human

  • Target Name

    UBE2QL1

  • Target Full Name

    Ubiquitin-conjugating enzyme E2Q-like protein 1

  • Target Function

    Probable E2 ubiquitin-protein ligase that catalyzes the covalent attachment of ubiquitin to target proteins. May facilitate the monoubiquitination and degradation of MTOR and CCNE1 through interaction with FBXW7.

  • Target Involvement

    A chromosomal aberration involving UBE2QL1 has been found in a sporadic case of renal cell carcinoma (RCC). Translocation t(5;19)(p15.3;q12). No gene is disrupted by the chromosome 19 breakpoint.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    Ubiquitin-conjugating enzyme family

  • Target Synonyms

    UBE2QL1; Ubiquitin-conjugating enzyme E2Q-like protein 1; EC 2.3.2.23; E2Q-like ubiquitin-conjugating enzyme 1

Inquire Recombinant Human Ubiquitin-conjugating enzyme E2Q-like protein 1 (UBE2QL1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification